Turner Investments’s Biogen BIIB Stock Holding History

Turner Investments’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,950	Closed	-$1.55M	–	205
2016 Q1	$1.55M	Sell	5,950 -3,765	-39%	-$995K	0.42%	83
2015 Q4	$2.98M	Buy	9,715 +9,565	+6,377%	+$2.75M	0.62%	58
2015 Q3	$44K	Sell	150 -1,860	-93%	-$614K	0.01%	234
2015 Q2	$812K	Buy	+2,010	New	+$807K	0.15%	193
2015 Q1	–	Sell	-6,757	Closed	-$2.29M	–	418
2014 Q4	$2.29M	Sell	6,757 -9,508	-58%	-$3.08M	0.27%	113
2014 Q3	$5.38M	Buy	16,265 +1,701	+12%	+$561K	0.32%	89
2014 Q2	$4.59M	Sell	14,564 -55,541	-79%	-$16.7M	0.2%	146
2014 Q1	$21.4M	Sell	70,105 -45,734	-39%	-$14.5M	0.57%	31
2013 Q4	$32.4M	Sell	115,839 -31,839	-22%	-$8.24M	0.58%	40
2013 Q3	$35.6M	Sell	147,678 -64,911	-31%	-$14.5M	0.59%	38
2013 Q2	$45.8M	Buy	+212,589	New	+$45.4M	0.62%	29

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Turner Investments's BIIB Position: Q2 2016 in Review

Turner Investments sold out of Biogen (BIIB) in Q2 2016, closing a stake of 5,950 shares — an estimated $1.55M sold.

Turner Investments first reported a position in BIIB in Q2 2013 and held it in 11 quarters. The position peaked at $45.8M in Q2 2013. 967 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

Turner Investments reported no remaining Biogen position as of Q2 2016 after selling out during the quarter.
Turner Investments sold 5,950 Biogen shares in Q2 2016, an estimated $1.55M.
Turner Investments first reported a position in Biogen in Q2 2013 and held it in 11 quarters.
Turner Investments's Biogen position peaked at $45.8M in Q2 2013.
967 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on Turner Investments's 13F filing for Q2 2016, filed 5 Aug 2016.